Skip to main content
. 2020 Jun 3;14:917–926. doi: 10.2147/PPA.S253732

Table 1.

Patient Characteristics Between Groups of AZA Adherence and Nonadherence

Features Adherence (n=259) Nonadherence (n=187) P value
Male (n [%]) 161(62.2) 99(52.9) 0.051
Age (Mean ± SD) 32.8±11.1 30.2±12.0 0.022
Married (n [%]) 137(52.9) 81(43.3) 0.046
Offspring (n [%]) 102(39.4) 76(40.6) 0.789
Education (n [%]) <0.001
Primary school 15(5.8) 3(1.6)
Secondary school 36(13.9) 13(7.0)
High school 95(36.7) 41(21.9)
College 100(38.6) 97(51.9)
Postgraduate 13(5.0) 33(17.6)
Family income per month (n [%]) 0.986
>10 thousand USD 21(8.1) 16(8.6)
 5–10 thousand USD 35(13.5) 22(11.8)
 2–5 thousand USD 77(29.7) 56(29.9)
 1–2 thousand USD 95(36.7) 69(36.9)
<1 thousand USD 31(12.0) 24(12.8)
Cost of disease per year (n [%]) 0.106
>10 thousand USD 67(25.9) 40(21.4)
 5–10 thousand USD 100(38.6) 91(48.7)
<5 thousand USD 92(35.5) 56(29.9)
Smoking (n [%]) 9(3.5) 11(5.9) 0.225
Alcoholism (n [%]) 3(1.2) 12(6.4) 0.002
Disease duration (yrs) (Mean ± SD) 4.7±2.5 4.9±2.4 0.420
Age of onset (n [%]) 0.357
<17 years old 24(9.3) 15(8.0)
 17–40 years old 217(83.8) 152(81.3)
>40 years old 18(6.9) 20(10.7)
Location of lesions (n [%]) 0.079
Ileum 113(43.6) 91(48.7)
Colon 37(14.3) 14(7.5)
Ileocolon 109(42.1) 82(43.9)
Behaviour (n [%]) 0.382
Non-stricture non-penetrating 181(69.9) 119(63.6)
Stricture 48(18.5) 42(22.5)
Penetrating 30(11.6) 26(13.9)
Perianal disease (n [%]) 83(32.0) 59(31.6) 0.912
CD-related surgery (n [%]) 44(17.0) 40(21.4) 0.241
Anxiety (Mean ± SD) 4.4±2.1 7.2±3.3 <0.001
Depression (Mean ± SD) 5.9±2.9 7.3±3.1 <0.001
AZA usage (n [%])
Dosage (mg/d) (Mean ± SD) 67.3±24.8 66.5±22.4 0.719
Duration (months) (Mean ± SD) 34.8±16.2 33.5±17.8 0.429
Necessity belief (Mean ± SD) 18.0±1.2 15.8±2.6 <0.001
Concerns belief (Mean ± SD) 14.8±2.0 17.0±1.8 <0.001
Knowledge (Mean ± SD) 6.0±1.8 5.6±1.8 0.016
Side effect (n [%]) 28(10.8) 18(9.6) 0.685

Abbreviations: SD, standard deviation; CD, Crohn’s disease; AZA, azathioprine.